“As Science noted in its story on the retracted paper, scientists are still debating whether the amyloid theory is viable. The skeptics cite the fraudulent research and lack of a genuine breakthrough; supporters can point to this new class of drugs including donanemab that have led to some improvement in some patients.”

https://www.vox.com/future-perfect/355108/alzheimers-disease-drug-approval-research-retraction